BioCentury
DATA GRAPHICS | Finance

Data Byte: IPO enthusiasm gives Dyne first-day pop as queue continues to grow

September 18, 2020 1:53 AM UTC

Dyne Therapeutics’ 26% pop on its first day of trading Thursday highlights continuing investor appetite for preclinical IPOs. 

The company raised $232.8 million through the sale of 12.3 million shares at $19 in the upsized offering; its aftermarket gains of $4.90 to $23.90 lifted its valuation to nearly $1 billion...